R Squared’s Organogenesis Holdings ORGO Stock Holding History

R Squared’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,260	Closed	-$13.6K	–	1126
2024 Q4	$13.6K	Buy	+4,260	New	+$14.3K	0.01%	1046

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R Squared's ORGO Position: Q1 2025 in Review

R Squared sold out of Organogenesis Holdings (ORGO) in Q1 2025, closing a stake of 4,260 shares — an estimated $13.6K sold.

R Squared first reported a position in ORGO in Q4 2024 and held it in 1 quarter. The position peaked at $13.6K in Q4 2024. 136 funds tracked by Wall St. Rank hold ORGO as of Q1 2025.

R Squared reported no remaining Organogenesis Holdings position as of Q1 2025 after selling out during the quarter.
R Squared sold 4,260 Organogenesis Holdings shares in Q1 2025, an estimated $13.6K.
R Squared first reported a position in Organogenesis Holdings in Q4 2024 and held it in 1 quarter.
R Squared's Organogenesis Holdings position peaked at $13.6K in Q4 2024.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.